Melissa Fanzaga, Gilda Aiello, Lorenza D’Adduzio, Giulia Ranaldi, Giovanna Boschin, Anna Arnoldi, Carlotta Bollati, Carmen Lammi
{"title":"乳肽的体外肠上皮转运、安全性和生物活性评价","authors":"Melissa Fanzaga, Gilda Aiello, Lorenza D’Adduzio, Giulia Ranaldi, Giovanna Boschin, Anna Arnoldi, Carlotta Bollati, Carmen Lammi","doi":"10.1155/jfbc/3531386","DOIUrl":null,"url":null,"abstract":"<p>This study aimed to evaluate the bioaccessibility, stability to brush border peptidases, bioavailability, intestinal safety, and bioactivity of low molecular weight (LMW)-milk protein hydrolysate on intestinal Caco-2 and STC-1 cellular models. Milk proteins were first subjected to simulated gastrointestinal digestion, and the resulting peptide mixture was analyzed for intestinal absorption using differentiated human Caco-2 cells. Using high-performance liquid chromatography-mass spectrometry (HPLC-MS), 82 peptides from casein and 16 peptides from β-lactoglobulin were identified as bioaccessible and stable, with some peptides already known to circulate in human plasma. Notably, 47% of apical peptides successfully crossed the epithelial barrier to the basolateral side. Importantly, the peptide mixtures preserved the intestinal monolayer integrity as shown by unchanged transepithelial electrical resistance (TEER) values at 5 mg/mL and demonstrated the intestinal safety through the absence of cytotoxicity in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability experiment in differentiated Caco-2 cells. Moreover, the bioactivity of the LMW-milk protein hydrolysate was assessed through in vitro and cell-based assays. Antioxidant potential was assessed using the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and ferric reducing antioxidant power (FRAP) assays, revealing a strong radical scavenging effect (up to 72.6%) and a FRAP increase of 3864% at 2.5 mg/mL. In addition, LMW hydrolysate significantly inhibited dipeptidyl peptidase-IV (DPP-IV) activity by 70.1% in vitro and 20.9% in Caco-2 cells at 10 mg/mL and stimulated glucagon-like peptide-1 (GLP-1) secretion in STC-1 cells by up to 122.4%. Finally, angiotensin-converting enzyme (ACE) inhibition reached 23% at 6.67 mg/mL in a dose-dependent manner. These findings demonstrate that LMW-milk peptides are safe, bioavailable, and exert multifunctional biological activities antioxidant, hypoglycemic, and hypotensive, supporting their potential application in functional food development.</p>","PeriodicalId":15802,"journal":{"name":"Journal of Food Biochemistry","volume":"2025 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jfbc/3531386","citationCount":"0","resultStr":"{\"title\":\"In Vitro Intestinal Transepithelial Transport, Safety, and Bioactivity Evaluation of Milk Peptides\",\"authors\":\"Melissa Fanzaga, Gilda Aiello, Lorenza D’Adduzio, Giulia Ranaldi, Giovanna Boschin, Anna Arnoldi, Carlotta Bollati, Carmen Lammi\",\"doi\":\"10.1155/jfbc/3531386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>This study aimed to evaluate the bioaccessibility, stability to brush border peptidases, bioavailability, intestinal safety, and bioactivity of low molecular weight (LMW)-milk protein hydrolysate on intestinal Caco-2 and STC-1 cellular models. Milk proteins were first subjected to simulated gastrointestinal digestion, and the resulting peptide mixture was analyzed for intestinal absorption using differentiated human Caco-2 cells. Using high-performance liquid chromatography-mass spectrometry (HPLC-MS), 82 peptides from casein and 16 peptides from β-lactoglobulin were identified as bioaccessible and stable, with some peptides already known to circulate in human plasma. Notably, 47% of apical peptides successfully crossed the epithelial barrier to the basolateral side. Importantly, the peptide mixtures preserved the intestinal monolayer integrity as shown by unchanged transepithelial electrical resistance (TEER) values at 5 mg/mL and demonstrated the intestinal safety through the absence of cytotoxicity in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability experiment in differentiated Caco-2 cells. Moreover, the bioactivity of the LMW-milk protein hydrolysate was assessed through in vitro and cell-based assays. Antioxidant potential was assessed using the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and ferric reducing antioxidant power (FRAP) assays, revealing a strong radical scavenging effect (up to 72.6%) and a FRAP increase of 3864% at 2.5 mg/mL. In addition, LMW hydrolysate significantly inhibited dipeptidyl peptidase-IV (DPP-IV) activity by 70.1% in vitro and 20.9% in Caco-2 cells at 10 mg/mL and stimulated glucagon-like peptide-1 (GLP-1) secretion in STC-1 cells by up to 122.4%. Finally, angiotensin-converting enzyme (ACE) inhibition reached 23% at 6.67 mg/mL in a dose-dependent manner. These findings demonstrate that LMW-milk peptides are safe, bioavailable, and exert multifunctional biological activities antioxidant, hypoglycemic, and hypotensive, supporting their potential application in functional food development.</p>\",\"PeriodicalId\":15802,\"journal\":{\"name\":\"Journal of Food Biochemistry\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jfbc/3531386\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Food Biochemistry\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/jfbc/3531386\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Food Biochemistry","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/jfbc/3531386","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
In Vitro Intestinal Transepithelial Transport, Safety, and Bioactivity Evaluation of Milk Peptides
This study aimed to evaluate the bioaccessibility, stability to brush border peptidases, bioavailability, intestinal safety, and bioactivity of low molecular weight (LMW)-milk protein hydrolysate on intestinal Caco-2 and STC-1 cellular models. Milk proteins were first subjected to simulated gastrointestinal digestion, and the resulting peptide mixture was analyzed for intestinal absorption using differentiated human Caco-2 cells. Using high-performance liquid chromatography-mass spectrometry (HPLC-MS), 82 peptides from casein and 16 peptides from β-lactoglobulin were identified as bioaccessible and stable, with some peptides already known to circulate in human plasma. Notably, 47% of apical peptides successfully crossed the epithelial barrier to the basolateral side. Importantly, the peptide mixtures preserved the intestinal monolayer integrity as shown by unchanged transepithelial electrical resistance (TEER) values at 5 mg/mL and demonstrated the intestinal safety through the absence of cytotoxicity in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability experiment in differentiated Caco-2 cells. Moreover, the bioactivity of the LMW-milk protein hydrolysate was assessed through in vitro and cell-based assays. Antioxidant potential was assessed using the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and ferric reducing antioxidant power (FRAP) assays, revealing a strong radical scavenging effect (up to 72.6%) and a FRAP increase of 3864% at 2.5 mg/mL. In addition, LMW hydrolysate significantly inhibited dipeptidyl peptidase-IV (DPP-IV) activity by 70.1% in vitro and 20.9% in Caco-2 cells at 10 mg/mL and stimulated glucagon-like peptide-1 (GLP-1) secretion in STC-1 cells by up to 122.4%. Finally, angiotensin-converting enzyme (ACE) inhibition reached 23% at 6.67 mg/mL in a dose-dependent manner. These findings demonstrate that LMW-milk peptides are safe, bioavailable, and exert multifunctional biological activities antioxidant, hypoglycemic, and hypotensive, supporting their potential application in functional food development.
期刊介绍:
The Journal of Food Biochemistry publishes fully peer-reviewed original research and review papers on the effects of handling, storage, and processing on the biochemical aspects of food tissues, systems, and bioactive compounds in the diet.
Researchers in food science, food technology, biochemistry, and nutrition, particularly based in academia and industry, will find much of great use and interest in the journal. Coverage includes:
-Biochemistry of postharvest/postmortem and processing problems
-Enzyme chemistry and technology
-Membrane biology and chemistry
-Cell biology
-Biophysics
-Genetic expression
-Pharmacological properties of food ingredients with an emphasis on the content of bioactive ingredients in foods
Examples of topics covered in recently-published papers on two topics of current wide interest, nutraceuticals/functional foods and postharvest/postmortem, include the following:
-Bioactive compounds found in foods, such as chocolate and herbs, as they affect serum cholesterol, diabetes, hypertension, and heart disease
-The mechanism of the ripening process in fruit
-The biogenesis of flavor precursors in meat
-How biochemical changes in farm-raised fish are affecting processing and edible quality